Theravance Biopharma Inc (TBPH) Stock Overview
Explore Theravance Biopharma Inc’s financial performance, market position, analyst ratings, and future outlook.
Theravance Biopharma Inc (TBPH)
Key Financials
Key Financials
Market Cap
871.2M
P/E Ratio
7.47
EPS (TTM)
$-0.08
ROE
0.44%
TBPH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Theravance Biopharma Inc (TBPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 50.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $23.28.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 7.47 and a market capitalization of 871.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.